Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK acts on faulty prostate cancer home-testing kits

This article was originally published in Clinica

Executive Summary

The UK's Medicines and Healthcare products Regulatory Agency today issued an alert urging all users of prostate cancer home-test screening kits manufactured by Biomerica in the last 12 months to seek medical advice. A single batch of 1,000 kits branded "Simplicity Health" or "Fortel" were the subject of a field safety notice issued by the Newport Beach, California firm to its distributors in August 2009, related to a "reduced stability" fault that posed a risk of a false negative. After recalling the faulty batch, the MHRA is now acting on concerns that users of kits may not be aware of the situation, or not able to trace the batch number.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel